Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression.

Context.-- Human epidermal growth factor receptor 2 (HER2) status in breast cancer is currently classified as negative or positive for selecting patients for anti-HER2 targeted therapy. The evolution of the HER2 status has included a new HER2-low category defined as an HER2 immunohistochemistry scor...

Descripción completa

Detalles Bibliográficos

Publicado en:	Archives of Pathology & Laboratory Medicine Vol. 148; no. 2; pp. 242 - 256
Autores principales:	Tozbikian, Gary, Krishnamurthy, Savitri, Bui, Marilyn M., Feldman, Michael, Hicks, David G., Jaffer, Shabnam, Khoury, Thaer, Shi Wei, Wen, Hannah, Pohlmann, Paula
Formato:	pictorial review tables/charts Journal Article
Publicado:	College of American Pathologists Feb2024
Acceso en línea:	Ver este registro en EBSCOhost